KRAS and pancreatic neoplasm: Thus, if KRAS is mutated in pancreatic cancer cells, inflammatory signals cause further secretion of cytokines and also lead to dysregulated activation of STAT3 as positive feedback, fueling KRAS-driven pancreatic cancer [5].